Halberd Corporation: Halberd Team Produces Peer Reviewed Article on Antibody Against Covid-19 Omicron Variant

Boosts effectiveness by 50% of commercially available Covid antibody in cocktailJACKSON CENTER, PA / ACCESSWIRE / November 30, 2022 / Halberd Corporation's (OTC PINK:HALB) Covid research has led to a scientific

Related Keywords

,Mitchells Felder ,Kostenloser Wertpapierhandel ,Williama Hartman ,Twitter ,Halberd Corporation ,Novel Plant Made Monoclonal Antibody Enhances ,Synergetic Potency ,Antibody Cocktail Against The ,Chief Technology Officer ,Private Securities Litigation Reform Act ,Halberd Corporationview ,Halberd ,Corporation ,Team ,Produces ,Beer ,Eviewed ,Article ,Ntibody ,Against ,Covid ,Micron ,Variant ,